Dopamine treatment for severe ovarian hyperstimulation syndrome.
Seven oliguric patients with severe ovarian hyperstimulation syndrome following gonadotrophin treatment for in-vitro fertilization or gamete intra-Fallopian transfer, were treated with low doses of dopamine by peripheral infusion. Five patients were pregnant. The rationale for this therapeutic approach was to increase renal blood flow and glomerular filtration. In addition to dopamine, fluid intake was restricted to 500 ml/day and a protein and salt-rich diet was provided in order to increase serum osmolarity. Within 24-48 h from the beginning of the dopamine treatment, the syndrome started to regress in all cases. No adverse maternal or fetal effects occurred. We conclude that dopamine therapy may constitute a major advance towards the management of severe ovarian hyperstimulation syndrome.
Ferraretti
A P
AP
Villa Regina, IVF Centre, Bologna, Italy.
Gianaroli
L
L
Diotallevi
L
L
Festi
C
C
Trounson
A
A
D004298:Dopamine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D009846:Oliguria / Q000178:diet therapy / Q000188:drug therapy; D016471:Ovarian Hyperstimulation Syndrome / Q000178:diet therapy / Q000188:drug therapy*; D011247:Pregnancy
D004298:Dopamine